

Author: Zatloukalová Libuše Filipský Tomáš Mladěnka Přemysl Semecký Vladimír Macáková Kateřina Holečková Magdalena Vávrová Jaroslava Palicka Vladimir Hrdina Radomír
Publisher: NRC Research Press
ISSN: 1205-7541
Source: Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.4, 2012-04, pp. : 473-484
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




The Burden of Moderate to Severe Psoriasis: An Overview
PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. :


Emerging drugs for moderate-to-severe psoriasis
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. :


Irbesartan/Hydrochlorothiazide: In Moderate to Severe Hypertension
By Croxtall Jamie D. Keating Gillian M.
Drugs, Vol. 68, Iss. 10, 2008-01 ,pp. :


Ustekinumab useful for moderate-to-severe plaque psoriasis
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :